Sciencast Management LP Nevro Corp Transaction History

Sciencast Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$59.95 - $92.06 $187,823 - $288,423	-3,133 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$81.07 - $121.29 $253,992 - $380,001	3,133 New	3,133 $279,000
Q3 2021 Oct 21, 2021	SELL	$101.99 - $166.36 $743,201 - $1.21 Million	-7,287 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$141.6 - $179.06 $178,132 - $225,257	1,258 Added 20.87%	7,287 $1.12 Million
Q1 2021 May 12, 2021	SELL	$132.81 - $182.18 $298,955 - $410,087	-2,251 Reduced 27.19%	6,029 $871,000
Q4 2020 Feb 04, 2021	BUY	$138.17 - $184.34 $895,341 - $1.19 Million	6,480 Added 360.0%	8,280 $1.41 Million
Q3 2020 Nov 02, 2020	BUY	$114.09 - $145.51 $205,362 - $261,917	1,800 New	1,800 $273,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $140M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Sciencast Management LP, based on Form 13F filings with the SEC.

Stay updated on Sciencast Management LP with notifications on news.